MicroRNAs in the p53 network: micromanagement of tumour suppression

Cited by (526)

Items 201–300 of 526

1. IRES mediated translational regulation of p53 isoforms
   Sharathchandra Arandkar, Aanchal Katoch, Saumitra Das · 2013 · Wiley Interdisciplinary Reviews - RNA
2. Heart Regeneration: Opportunities and Challenges for Drug Discovery with Novel Chemical and Therapeutic Methods or Agents
   Alleyn T. Plowright, Ola Engkvist, Adrian L. Gill, Laurent Knerr, Qing‐Dong Wang · 2014 · Angewandte Chemie International Edition
3. Synergetic regulatory networks mediated by oncogene-driven microRNAs and transcription factors in serous ovarian cancer
   Min Zhao, Jingchun Sun, Zhongming Zhao · 2013 · Molecular BioSystems
4. The emerging role of long non-coding RNA in gallbladder cancer pathogenesis
   Akanksha Khandelwal, Akshay Malhotra, Manju Jain, Karen M. Vásquez, Aklank Jain · 2016 · Biochimie
5. Cardiac ageing: from hallmarks to therapeutic opportunities
   Margaret H. Hastings, Qiulian Zhou, Chao Wu, Parisa Shabani, Shengyuan Huang, Xuejing Yu, Anand Prakash Singh, James Sawalla Guseh, Haobo Li, Carolin Lerchenmüller et al. · 2024 · Cardiovascular Research
6. mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis
   Cristina Borzi, Linda Calzolari, Giovanni Centonze, Massimo Milione, Gabriella Sozzi, Orazio Fortunato · 2017 · International Journal of Molecular Sciences
7. The “Macro” World of microRNAs in Hepatocellular Carcinoma
   Kaveri Sidhu, Neetu Rohit Kapoor, Vijaya Pandey, Vijay Kumar · 2015 · Frontiers in Oncology
8. The Pharmacodynamics of the p53-Mdm2 Targeting Drug Nutlin: The Role of Gene-Switching Noise
   Krzysztof Puszyński, Alberto Gandolfi, Alberto d’Onofrio · 2014 · PLoS Computational Biology
9. TP53/MicroRNA Interplay in Hepatocellular Carcinoma
   Daniela Pollutri, Laura Gramantieri, Luigi Bolondi, Francesca Fornari · 2016 · International Journal of Molecular Sciences
10. p53 regulates cytoskeleton remodeling to suppress tumor progression
    Keigo Araki, Takahiro Ebata, Alvin Kunyao Guo, Kei Tobiume, Steven John Wolf, Keiko Kawauchi · 2015 · Cellular and Molecular Life Sciences
11. Modulated expression of human peripheral blood micro RNA s from infancy to adulthood and its role in aging
    Lai, Chi‐Yu, Wu, Yen‐Tzu, Yu, Sung‐Liang, Yu, Ya‐Hui, Lee, Su‐Yin, Liu, Chih‐Min, Hsieh, Wu‐Shiun, Hwu, Hai‐Gwo, Chen, Pau‐Chung, Jeng, Suh‐Fang et al. · 2014 · Aging Cell
12. p53 downregulates PD-L1 expression via miR-34a to inhibit the growth of triple-negative breast cancer cells: a potential clinical immunotherapeutic target
    Siyu Deng, Mengna Wang, Chenglong Wang, Yan Zeng, Xue Ying Qin, Yiwen Tan, Bing Liang, Youde Cao · 2022 · Molecular Biology Reports
13. MicroRNA-9 regulates osteoblast differentiation and angiogenesis via the AMPK signaling pathway
    Jining Qu, Daigang Lu, Hua Guo, Wusheng Miao, Ge Wu, Meifen Zhou · 2015 · Molecular and Cellular Biochemistry
14. Genome-wide analysis of p53 transcriptional programs in B cells upon exposure to genotoxic stress in vivo
    Claudia Tonelli, Marco J. Morelli, Salvatore Bianchi, Luca Rotta, Thelma Capra, Arianna Sabò, Stefano Campaner, Bruno B. Amati · 2015 · Oncotarget
15. miR-620 promotes tumor radioresistance by targeting 15-hydroxyprostaglandin dehydrogenase (HPGD)
    Xiaoyong Huang, Samira Taeb, Sahar Jahangiri, Elina Korpela, Ivan G. Cadonic, Nancy Yu, Sergey N. Krylov, Emmanouil Fokas, Paul Christopher Boutros, Stanley K. Liu · 2015 · Oncotarget
16. ADAR-mediated RNA editing in non-coding RNA sequences
    Yun Yang, Xinxin Zhou, Yongfeng Jin · 2013 · Science China Life Sciences
17. Down Regulation of miR-34a and miR-143 May Indirectly Inhibit p53 in Oral Squamous Cell Carcinoma: a Pilot Study
    Mayakannan Manikandan, Arunagiri Kuha Deva Magendhra Rao, Ganesan Arunkumar, Rajkumar Kottayasamy Seenivasagam, Ramamurthy Rajaraman, Arasambattu Kannan Munirajan · 2015 · Asian Pacific Journal of Cancer Prevention
18. Therapeutic Potential of the miRNA–ATM Axis in the Management of Tumor Radioresistance
    Abdol-Hossein Rezaeian, Hashem Khanbabaei, George A. Călin · 2019 · Cancer Research
19. Anti-tumoral effect of desmethylclomipramine in lung cancer stem cells
    Lucilla Bongiorno‐Borbone, Arianna Giacobbe, Mirco Compagnone, Adriana Eramo, Ruggero D. Maria, Angelo Peschiaroli, Gerry Melino · 2015 · Oncotarget
20. Arsenic exposure disrupts epigenetic regulation of SIRT1 in human keratinocytes
    Katharine J. Herbert, Adele F. Holloway, Anthony L. Cook, Paulynn Suyin Chin, Elizabeth T. Snow · 2014 · Toxicology and Applied Pharmacology
21. Genome wide expression profiling of p53 regulated miRNAs in neuroblastoma
    Ali Rihani, Alan Van Goethem, Maté Ongenaert, Sara De Brouwer, Pieter‐Jan Volders, Saurabh Agarwal, Katleen De Preter, Pieter Mestdagh, Jason Matthew Shohet, Frank Speleman et al. · 2015 · Scientific Reports
22. Interplay Between Transcription Factors and MicroRNAs Regulating Epithelial-Mesenchymal Transitions in Colorectal Cancer
    Markus Kaller, Heiko Hermeking · 2016 · Advances in experimental medicine and biology
23. MicroRNA‑223‑induced inhibition of the FBXW7 gene affects the proliferation and apoptosis of colorectal cancer cells via the Notch and Akt/mTOR pathways
    Zhixin Liu, Teng Ma, Jufeng Duan, Xiaofei Liu, Long Liu · 2020 · Molecular Medicine Reports
24. Mutual exclusivity of ESR1 and TP53 mutations in endocrine resistant metastatic breast cancer
    Zheqi Li, Nicole S. Spoelstra, Matthew J. Sikora, Sharon B. Sams, ANTHONY D. ELIAS, Jennifer K. Richer, Adrian V. Lee, Steffi Oesterreich · 2022 · npj Breast Cancer
25. Deregulated microRNAs Involved in Prostate Cancer Aggressiveness and Treatment Resistance Mechanisms
    Himali Gujrati, Siyoung Ha, Bi‐Dar Wang · 2023 · Cancers
26. p53 at the crossroad between mitochondrial reactive oxygen species and necroptosis
    Sergio Rius‐Pérez · 2023 · Free Radical Biology and Medicine
27. Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer
    Konstantinos Gus Sidiropoulos, Nicole M. A. White, Anna Bui, Qiang Ding, Peter Boulos, Georgios Pampalakis, Heba W. Z. Khella, Joseph N. Samuel, Georgia Sotiropoulou, George Makram Yousef · 2014 · Oncoscience
28. CDK1 interacts with iASPP to regulate colorectal cancer cell proliferation through p53 pathway
    Wei Gan, Hua Zhao, Tiegang Li, Kuijie Liu, Jiangsheng Huang · 2017 · Oncotarget
29. miR-524-5p of the primate-specific C19MC miRNA cluster targets TP53IPN1- and EMT-associated genes to regulate cellular reprogramming
    Phan Nguyen Nhi Nguyen, Kong‐Bung Choo, Chiu-Jung Huang, Shigeki Sugii, Soon Keng Cheong, Tunku Kamarul · 2017 · Stem Cell Research & Therapy
30. miR‐22 enhances the radiosensitivity of small‐cell lung cancer by targeting the WRNIP1
    Wenhua Jiang, Xuemei Han, Jingrui Wang, Lin Wang, Zanmei Xu, Wei Qiao, Wenpan Zhang, Haitao Wang · 2019 · Journal of Cellular Biochemistry
31. p53: Its Mutations and Their Impact on Transcription
    Catherine A. Vaughan, Isabella Pearsall, William Andrew Yeudall, Swati Palit Deb, Sumitra Deb · 2014 · Sub-cellular biochemistry/Subcellular biochemistry
32. Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer
    Gaoxiang Wang, X Cao, Senyan Lai, Xuelai Luo, Yongdong Feng, Jingjing Wu, Qin Ning, Xi Xia, J Wang, J Gong et al. · 2014 · Oncogene
33. Battle Against Cancer: An Everlasting Saga of p53
    Qian Hao, William Cho · 2014 · International Journal of Molecular Sciences
34. Non-coding RNAs in DNA damage response.
    Yunhua Liu, Xiongbin Lu · 2012 · PubMed Central
35. The effect of adenosine A1 receptor agonist and antagonist on p53 and caspase 3, 8, and 9 expression and apoptosis rate in MCF-7 breast cancer cell line
    Mehdi Nikbakht Dastjerdi, MohammadZamani Rarani, Ali Valiani, Mohsen Mahmoudieh · 2016 · Research in Pharmaceutical Sciences
36. Etoposide-resistance in a neuroblastoma model cell line is associated with 13q14.3 mono-allelic deletion and miRNA-15a/16-1 down-regulation
    Barbara Marengo, Paola Monti, Mariangela Miele, Paola Menichini, Laura Ottaggio, Giorgia Foggetti, Alessandra Pulliero, Alberto Izzotti, Andrea Speciale, Ombretta Garbarino et al. · 2018 · Scientific Reports
37. Time‐series transcriptomics and proteomics reveal alternative modes to decode p53 oscillations
    Alba Jiménez, Dan Lü, Marian Kalocsay, Matthew J. Berberich, Petra Balbi, Ashwini Jambhekar, Galit Lahav · 2022 · Molecular Systems Biology
38. Growth differentiation factor-15 encodes a novel microRNA 3189 that functions as a potent regulator of cell death
    Matthew F. Jones, X Ling Li, M Subramanian, Svetlana A. Shabalina, Toshifumi Hara, Yuelin Jack Zhu, Jing Li Huang, Yandan Yang, Lalage M. Wakefield, Kannanganattu V. Prasanth et al. · 2015 · Cell Death and Differentiation
39. Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy
    Hsiang-Hao Chuang, Yen‐Yi Zhen, Yu-Chen Tsai, Cheng‐Hao Chuang, Ming‐Shyan Huang, Michael Hsiao, Chih‐Jen Yang · 2021 · Biomedicines
40. Loss of MIR15A and MIR16‐1 at 13q14 is associated with increased TP53 mRNA , de‐repression of BCL2 and adverse outcome in chronic lymphocytic leukaemia
    Ke Lin, Mosavar Farahani, Yi Yang, Gillian G. Johnson, Melanie Oates, Mark Atherton, Angela Douglas, Nagesh Kalakonda, Andrew R. Pettitt · 2014 · British Journal of Haematology
41. Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells
    Rebecca A. Rowehl, Stephanie Burke, Agnieszka B. Bialkowska, Donald W. Pettet, Leahana Rowehl, Ellen Li, Eric Antoniou, Yuanhao Zhang, Roberto C. Bergamaschi, Kenneth Reed Shroyer et al. · 2014 · PLoS ONE
42. Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome
    Yao Zhang, Ye Hu, Jing‐Yuan Fang, Jie Xu · 2016 · Oncotarget
43. MicroRNA-138 Inhibits Cell Growth, Invasion, and EMT of Non-Small Cell Lung Cancer via SOX4/p53 Feedback Loop
    Dandan Li, Changjun He, Junfeng Wang, Yanbo Wang, Jianlong Bu, Xianglong Kong, Dawei Sun · 2017 · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · Retracted
44. Prognostic Significance of MicroRNAs in Glioma: A Systematic Review and Meta-Analysis
    Zhang, Yanming, Chen, Jigang, Xue, Qiang, Wang, Junyu, Zhao, Liang, Han, Kaiwei, Zhang, Danfeng, Hou, Lijun · 2019 · BioMed Research International
45. A Circular RNA from the MDM2 Locus Controls Cell Cycle Progression by Suppressing p53 Levels
    Ritu Chaudhary, Bruna Rodrigues Muys, Ioannis Grammatikakis, Supriyo De, Kotb Abdelmohsen, Xiao Ling Li, Yuelin Jack Zhu, Swapna Vidhur Daulatabad, Dimitrios Tsitsipatis, Paul S. Meltzer et al. · 2020 · Molecular and Cellular Biology
46. The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
    Wenwei Liao, Jinpeng Du, Zhen Wang, Qingbo Feng, Mingheng Liao, Huixian Liu, Kefei Yuan, Yong Zeng · 2022 · International Journal of Cancer
47. Glutamine, Glucose and other Fuels for Cancer
    María Victoria Ruiz-Pérez, Francisca Sánchez‐Jiménez, Francisco José Alonso, Juan Segura, Javier Márquez, Miguel Ángel Medina · 2014 · Current Pharmaceutical Design
48. SolubleIL6Rrepresents a miR-34a target: potential implications for the recently identified IL-6R/STAT3/miR-34a feed-back loop
    Huihui Li, Matjaž Rokavec, Heiko Hermeking · 2015 · Oncotarget
49. TP53-inducible putative long noncoding RNAs encode functional polypeptides that suppress cell proliferation
    Wenli Xu, Chang Liu, Bing Deng, Penghui Lin, Zhenghua Sun, Anrui Liu, Jiajia Xuan, Yuying Li, Keren Zhou, Xiaoqin Zhang et al. · 2022 · Genome Research
50. p53 rapidly restructures 3D chromatin organization to trigger a transcriptional response
    François Serra, Andrea Nieto-Aliseda, Lucía Fanlo, Llorenç Rovirosa, Mónica Cabrera-Pasadas, Aleksey Lazarenkov, Blanca Urmeneta, Alvaro Alcalde-Merino, E. Nola, Andrei L. Okorokov et al. · 2024 · Nature Communications
51. KLK6‐regulated miRNA networks activate oncogenic pathways in breast cancer subtypes
    Konstantinos Gus Sidiropoulos, Qiang Ding, Georgios Pampalakis, Nicole M. A. White, Peter Boulos, Georgia Sotiropoulou, George Makram Yousef · 2016 · Molecular Oncology
52. Macro advances in microRNAs and myocardial regeneration
    Jun Wang, James F. Martin · 2014 · Current Opinion in Cardiology
53. miR-600 inhibits cell proliferation, migration and invasion by targeting p53 in mutant p53-expressing human colorectal cancer cell lines
    Peili Zhang, Zhigui Zuo, Aihua Wu, Wenjing Shang, Ruichun Bi, Qike Jin, Jianbo Wu, Lei Jiang · 2017 · Oncology Letters
54. Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways
    Yi-Jin Chen, Wen–Hung Wang, Wanyu Wu, Chia‐Chi Hsu, Ling-Rung Wei, Sheng‐Fan Wang, Ya-Wen Hsu, Chih‐Chuang Liaw, Wan-Chi Tsai · 2017 · PLoS ONE
55. Involvement of miR-605 and miR-34a in the DNA Damage Response Promotes Apoptosis Induction
    Chun-Hong Zhou, Xiao‐Peng Zhang, Feng Liu, Wei Wang · 2014 · Biophysical Journal
56. MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation
    Yuhuang Li, Kishore B. Challagundla, Xiao‐Xin Sun, Qinghong Zhang, Mu‐Shui Dai · 2014 · Oncotarget
57. The network of pluripotency, epithelial–mesenchymal transition, and prognosis of breast cancer
    Ioannis A. Voutsadakis · 2015 · Breast Cancer Targets and Therapy
58. Paracrine Induction of Epithelial-Mesenchymal Transition Between Colorectal Cancer Cells and its Suppression by a p53/miR-192/215/NID1 Axis
    Matjaž Rokavec, Nassim Bouznad, Heiko Hermeking · 2019 · Cellular and Molecular Gastroenterology and Hepatology
59. Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
    Maryam Zanjirband, Soheila Rahgozar · 2019 · Current Drug Targets
60. Targeting microRNAs with thymoquinone: a new approach for cancer therapy
    Mina Homayoonfal, Zatollah Asemi, Bahman Yousefi · 2021 · Cellular & Molecular Biology Letters
61. The Complex Interaction between P53 and miRNAs Joins New Awareness in Physiological Stress Responses
    Camilla Capaccia, Silvana Diverio, Danilo Zampini, Gabriella Guelfi · 2022 · Cells
62. Transcriptional regulation of microRNA-100, −146a, and −150 genes by p53 and NFκB p65/RelA in mouse striatal STHdhQ7/ HdhQ7cells and human cervical carcinoma HeLa cells
    Jayeeta Ghose, Nitai Pada Bhattacharyya · 2015 · RNA Biology
63. Micro RNA ‐34c‐5p is related to recurrence in laryngeal squamous cell carcinoma
    Massimo Re, Artan Çeka, Corrado Rubini, Luigi Ferrante, Antonio Zizzi, Federico Maria Gioacchini, Michele Tulli, Liana Spazzafumo, Stefano Sellari‐Franceschini, Antonio Domenico Procopio et al. · 2015 · The Laryngoscope
64. The DEAD-box RNA helicase DDX41 is a novel repressor of p21WAF1/CIP1 mRNA translation
    Dominik Peters, Claudia Radine, Alina Reese, Wilfried Budach, Dennis Sohn, Reiner U. Jänicke · 2017 · Journal of Biological Chemistry
65. Dynamics of P53 in response to DNA damage: Mathematical modeling and perspective
    Tingzhe Sun, Jun Cui · 2015 · Progress in Biophysics and Molecular Biology
66. MicroRNAs, cancer and ionizing radiation: Where are we?
    Gustavo Nader Marta, Bernardo Garicochea, André Lopes Carvalho, Juliana Monte Real, Luiz Paulo Kowalski · 2015 · Revista da Associação Médica Brasileira
67. Integrated transcriptome analysis reveals miRNA–mRNA crosstalk in laryngeal squamous cell carcinoma
    Yang Zhang, Yong Chen, Jinhai Yu, Guiming Liu, Zhigang Huang · 2014 · Genomics
68. The P53 Mirna Interactome and its Potential Role in the Cancer Clinic
    Jonathan Krell, Adam Enver Frampton, Teresa Colombo, Tamara Gall, Alex de Giorgio, Victoria Harding, Justin Stebbing, Leandro Castellano · 2013 · Epigenomics
69. miR-34 inhibits growth and promotes apoptosis of osteosarcoma in nude mice through targetly regulating TGIF2 expression
    Liang Xi, Yongfeng Zhang, Shengnan Kong, Wei Liang · 2018 · Bioscience Reports · Retracted
70. Mutant p53 Attenuates Oxidative Phosphorylation and Facilitates Cancer Stemness through Downregulating miR-200c–PCK2 Axis in Basal-Like Breast Cancer
    Chi-Hong Chao, Chen-Yun Wang, Cing-Hong Wang, Ting-Wen Chen, Huai-Yu Hsu, Hao-Wei Huang, Chia‐Wei Li, Ru-Tsun Mai · 2021 · Molecular Cancer Research
71. From tumor prevention to therapy: Empowering p53 to fight back
    Christian Frezza, Carla P. Martins · 2012 · Drug Resistance Updates
72. p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs
    Shanna Stanley-Hasnain, Ludger Hauck, Daniela Grothe, Roozbeh Aschar‐Sobbi, Sanja Beca, JAGDISH W. BUTANY, Peter H. Backx, Tak W. Mak, Filio Billia · 2017 · Cell Cycle
73. p53 regulates CD46 expression and measles virus infection in myeloma cells
    Anne Lok, Géraldine Descamps, Benoît Tessoulin, David Chiron, Marion Eveillard, Catherine Godon, Yannick Le Bris, Astrid Vabret, Céline Bellanger, Laurent Maillet et al. · 2018 · Blood Advances
74. P53-dependent miRNAs mediate nitric oxide-induced apoptosis in colonic carcinogenesis
    Weiwei Li, Wenxiao Han, Yiming Ma, Liang Richard Cui, Yantao Tian, Zhixiang Zhou, Hongying Wang · 2015 · Free Radical Biology and Medicine
75. miR‐124 exhibits antiproliferative and antiaggressive effects on prostate cancer cells through PACE4 pathway
    Shaosan Kang, Yansheng Zhao, Kaimeng Hu, Chen Xu, Lei Wang, Jian Liu, Anliang Yao, Hongmei Zhang, Fenghong Cao · 2014 · The Prostate
76. Dynamics of DNA Damage Induced Pathways to Cancer
    Kun Tian, Ramkumar Rajendran, Manjula Doddananjaiah, Marija Krstic–Demonacos, Jean‐Marc Schwartz · 2013 · PLoS ONE
77. miR‐9, miR‐21, miR‐27b, and miR‐34a Expression in HPV16/58/52‐Infected Cervical Cancer
    Mi Liu, Wei Ting Wang, Haixing Chen, Yi Lu, Daisha Yuan, Yongjiu Deng, Danlu Ran · 2020 · BioMed Research International
78. Distinct roles of miR-34 family members on suppression of lung squamous cell carcinoma
    Dangze Sun, Wu Yao, Shanshan Zhang, Yaxuan Han, Jinglong Shen, Wenhao Zheng, Wei Lin, Yugang Liu, Leipeng Ren, Zhenning Gu et al. · 2021 · Biomedicine & Pharmacotherapy
79. Natural substances derived from herbs or plants are promising sources of anticancer agents against colorectal cancer via triggering apoptosis
    Zibo Liu, Ting Zhang, Xun Ye, Ziqi Liu, Xue Sun, Li-Lin Zhang, Chunjie Wu · 2021 · Journal of Pharmacy and Pharmacology
80. MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
    Ippei Kawano, Michaela Adamcová · 2022 · Frontiers in Pharmacology
81. Genomic alterations as mediators of miRNA dysregulation in ovarian cancer
    Casina W.S. Kan, Viive Maarika Howell, Michael A. Hahn, Deborah J. Marsh · 2014 · Genes Chromosomes and Cancer
82. Deciphering the RNA landscape by RNAome sequencing
    Kasper Derks, Branislav Mišovic, Mirjam C. G. N. van den Hout, Christel E. M. Kockx, César Payán‐Gómez, Rutger W. W. Brouwer, Harry Vrieling, Jan H.J. Hoeijmakers, Wilfred F. J. van IJcken, Joris Pothof · 2015 · RNA Biology
83. SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells
    Eriko Shinozuka, Masao Miyashita, Yoshiaki Mizuguchi, Ichiro Akagi, Kunio Kikuchi, Hiroshi Makino, Takeshi Matsutani, Nobutoshi Hagiwara, Tsutomu Nomura, Eiji Uchida et al. · 2012 · Biochemical and Biophysical Research Communications
84. Non-Coding RNA: Sequence-Specific Guide for Chromatin Modification and DNA Damage Signaling
    Sofia Francia · 2015 · Frontiers in Genetics
85. Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
    Yilin Li, Jun Ye, Shun Xu, Jiajun Wang · 2023 · Discover Oncology
86. Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer
    Feng Wang, Yanlei Ma, Huamin Wang, Huanlong Qin · 2017 · Oncology Letters
87. The prognostic value of long noncoding RNA MEG3 expression in the survival of patients with cancer: A meta‐analysis
    Maryam Moradi Binabaj, Afsane Bahrami, Amirhossein Bahreyni, Mojtaba Shafiee, Farzad Rahmani, Majid Khazaei, Saman Soleimanpour, Elnaz Ghorbani, Hamid Fiuji, Gordon A. Ferns et al. · 2018 · Journal of Cellular Biochemistry
88. CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma
    Hui Wang, Xuming Song, Yajing Wang, Yin Xuewen, Yingkuan Liang, Te Zhang, Lin Xu, Feng Jiang, Gaochao Dong · 2020 · Cell Death and Disease
89. The p53/miR-145a Axis Promotes Cellular Senescence and Inhibits Osteogenic Differentiation by Targeting Cbfb in Mesenchymal Stem Cells
    Chao Xia, Tianyuan Jiang, Yonghui Wang, Xiaoting Chen, Yan Hu, Yanhong Gao · 2021 · Frontiers in Endocrinology
90. Endogenous p53 expression in human and mouse is not regulated by its 3′UTR
    Sibylle Mitschka, Christine Mayr · 2021 · eLife
91. Rare germline variant (rs78378222) in the TP53 3' UTR: Evidence for a new mechanism of cancer predisposition in Li-Fraumeni syndrome
    Gabriel S. Macedo, Igor Araújo Vieira, Ana Paula Carneiro Brandalize, Juliana Giacomazzi, Edenir Inêz Palmero, Sáhlua Miguel Volc, Vanessa Rodrigues Paixão‐Côrtes, Maira M Caleffi, Michele Silva Alves, Maria Isabel Achatz et al. · 2016 · Cancer Genetics
92. Increased Sensitivity to Chemotherapy Induced by CpG-ODN Treatment Is Mediated by microRNA Modulation
    Loris De Cecco, Martina Berardi, Michele Sommariva, Alessandra Cataldo, Silvana Canevari, Delia Mezzanzanica, Marilena Valeria Iorio, Elda Tagliabue, Andrea Balsari · 2013 · PLoS ONE
93. Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways
    Aishwarya G. Jacob, Ravi Kumar Singh, Daniel F. Comiskey, Matthew F. Rouhier, Fuad Mohammad, Thomas W. Bebee, Dawn S. Chandler · 2014 · PLoS ONE
94. Cross‐talk between Myc and p53 in B‐cell lymphomas
    Yu Li, Tiantian Yu, Ken H. Young · 2019 · Chronic Diseases and Translational Medicine
95. Identifying the differentially expressed peripheral blood microRNAs in psychiatric disorders: a systematic review and meta-analysis
    Xiaoyan Liu, Liying Dong, Zhaowei Jiang, Mingfen Song, Pan Yan · 2024 · Frontiers in Psychiatry
96. Profiling the microRNA Expression in Human iPS and iPS-derived Retinal Pigment Epithelium
    Heuy-Ching Hetty Wang, Whitney A. Greene, Ramesh R. Kaini, Jane Shen-Gunther, Hung-I H. Chen, Hong Car, Yufeng Wang · 2014 · Cancer Informatics
97. Keeping an open mind: highlights and controversies of the breast cancer stem cell theory
    Cinzia Allegrucci, Mansi Shah · 2012 · Breast Cancer Targets and Therapy
98. miR-34a suppresses proliferation and induces apoptosis of human lens epithelial cells by targeting E2F3
    Wu Xiang, Haotian Lin, Qilin Wang, Wan Chen, Zhaochuan Liu, Hui Chen, Hui Zhang, Weirong Chen · 2016 · Molecular Medicine Reports
99. Loss of p53-inducible long non-coding RNA LINC01021 increases chemosensitivity
    Markus Kaller, Ursula Götz, Heiko Hermeking · 2017 · Oncotarget
100. Functions and epigenetic aspects of miR-15/16: Possible future cancer therapeutics
     Mekala Janaki Ramaiah · 2018 · Gene Reports